原发性肝癌的治疗,近几年进展最活跃的领域就是肝动脉栓塞术(Hepatic Artery Embolization,HAE).自Goldstein于1976年首先用HAE治疗肝癌以后,HAE即被迅速广泛地用于肝癌的治疗,通过十多年的观察和改进,取得了良好的治疗效果,尤其是对占大多数的不能切除的中晚期肝癌,已成为首选疗法.然而,HAE的治疗效果仍不是很理想,有许多问题亟待解决. In the treatment of primary liver cancer, the area with the most active progress in recent years is Hepatic Artery Embolization (HAE). Since the first HAE treatment of liver cancer by Goldstein in 1976, HAE has been rapidly and extensively used for liver cancer. Treatment, through more than 10 years of observation and improvement, has achieved a good therapeutic effect, especially for the majority of unresectable advanced liver cancer, has become the preferred therapy. However, the HAE treatment effect is still not very satisfactory, there are many The problem needs to be solved.